Anaerobe-Targeted Antibiotic Therapy in the Neonatal Intensive Care Unit
Anaerobe-targeted antibiotic (ATA) therapy may adversely impact the developing neonatal microbiome. We describe utilization patterns, potential indications, and related outcomes of ATA therapy in neonatal intensive care units across the United States over 13 years. While overall antibiotic use decreased, ATA use was unchanged. Potentially associated indications were inconsistent.
Authors
- Sagori Mukhopadhyay (ORCID: https://orcid.org/0000-0002-5851-8414)
- Matthew B Green (ORCID: https://orcid.org/0000-0003-3903-7567)
- Karen Marie Puopolo (ORCID: https://orcid.org/0000-0002-5581-8825)
- Dustin D. Flannery (ORCID: https://orcid.org/0000-0003-2883-4683)
- Jeffrey S. Gerber (ORCID: https://orcid.org/0000-0002-3076-3186)
- Alvaro Zevallos Barboza
- Michael J. Morowitz (ORCID: https://orcid.org/0000-0001-8172-637X)
Institutions
- Children's Hospital of Philadelphia (US)
- University of Pittsburgh (US)
- Rowan University (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Journal of the Pediatric Infectious Diseases Society
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1093/jpids/piae109
- Citations
- 1
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.39